Kodiak Sciences KOD Stock
Kodiak Sciences Price Chart
Kodiak Sciences KOD Financial and Trading Overview
| Kodiak Sciences stock price | 4.12 USD |
| Previous Close | 9.03 USD |
| Open | 9 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 1000 |
| Day's Range | 8.77 - 9.32 USD |
| 52 Week Range | 4.25 - 12.8 USD |
| Volume | 471.06K USD |
| Avg. Volume | 576.74K USD |
| Market Cap | 482.2M USD |
| Beta (5Y Monthly) | 1.744013 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.35 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 12.25 USD |
KOD Valuation Measures
| Enterprise Value | 135.8M USD |
| Trailing P/E | N/A |
| Forward P/E | -2.436508 |
| PEG Ratio (5 yr expected) | -0.15 |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.2213235 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.434 |
Trading Information
Kodiak Sciences Stock Price History
| Beta (5Y Monthly) | 1.744013 |
| 52-Week Change | 16.43% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 12.8 USD |
| 52 Week Low | 4.25 USD |
| 50-Day Moving Average | 5.91 USD |
| 200-Day Moving Average | 7.01 USD |
KOD Share Statistics
| Avg. Volume (3 month) | 576.74K USD |
| Avg. Daily Volume (10-Days) | 1.1M USD |
| Shares Outstanding | 52.36M |
| Float | 31.8M |
| Short Ratio | 3.81 |
| % Held by Insiders | 5.69% |
| % Held by Institutions | 80.45% |
| Shares Short | 1.85M |
| Short % of Float | 5.39% |
| Short % of Shares Outstanding | 3.52% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -26.85% |
| Return on Equity (ttm) | -62.40% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -312919008 USD |
| Net Income Avi to Common (ttm) | -308894016 USD |
| Diluted EPS (ttm) | -5.89 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 421.19M USD |
| Total Cash Per Share (mrq) | 8.09 USD |
| Total Debt (mrq) | 86.75M USD |
| Total Debt/Equity (mrq) | 22.1 USD |
| Current Ratio (mrq) | 6.254 |
| Book Value Per Share (mrq) | 7.541 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -210520000 USD |
| Levered Free Cash Flow (ttm) | -132880496 USD |
Profile of Kodiak Sciences
| Country | United States |
| State | CA |
| City | Palo Alto |
| Address | 1200 Page Mill Road |
| ZIP | 94304 |
| Phone | (650) 281-0850 |
| Website | https://kodiak.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 115 |
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as Phase III clinical study for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet biopolymer conjugate for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.
Q&A For Kodiak Sciences Stock
What is a current KOD stock price?
Kodiak Sciences KOD stock price today per share is 4.12 USD.
How to purchase Kodiak Sciences stock?
You can buy KOD shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Kodiak Sciences?
The stock symbol or ticker of Kodiak Sciences is KOD.
Which industry does the Kodiak Sciences company belong to?
The Kodiak Sciences industry is Biotechnology.
How many shares does Kodiak Sciences have in circulation?
The max supply of Kodiak Sciences shares is 52.75M.
What is Kodiak Sciences Price to Earnings Ratio (PE Ratio)?
Kodiak Sciences PE Ratio is now.
What was Kodiak Sciences earnings per share over the trailing 12 months (TTM)?
Kodiak Sciences EPS is -3.35 USD over the trailing 12 months.
Which sector does the Kodiak Sciences company belong to?
The Kodiak Sciences sector is Healthcare.
Kodiak Sciences KOD included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16708.05 USD — |
+2.5
|
7.43B USD — | 16642.66 USD — | 17029.86 USD — | — - | 7.43B USD — |
| Stlmt ID NASDAQ Biotechnology NBX | 4124.19 USD — |
+3.5
|
— — | 3927.42 USD — | 4124.19 USD — | — - | — — |
| NASDAQ Global Market Composite NQGM | 1840.25 USD — |
+3.2
|
— — | 1832.76 USD — | 1881.09 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4115.11 USD — |
+1.65
|
— — | 4101.26 USD — | 4187.02 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 912.02 USD — |
+1.75
|
— — | 909.85 USD — | 929.8 USD — | — - | — — |
- {{ link.label }} {{link}}